Clinical activity of arsenic trioxide in Burkitt-like lymphoma.
Ravandi
F
F
van Besien
K
K
D000208:Acute Disease; D000328:Adult; D015703:Antigens, CD / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000473:pathology; D010087:Oxides / Q000627:therapeutic use*; D016879:Salvage Therapy; D016896:Treatment Outcome
D015703:Antigens, CD; D000970:Antineoplastic Agents; D000975:Antioxidants; D001152:Arsenicals; D010087:Oxides; D007770:L-Lactate Dehydrogenase; D001205:Ascorbic Acid; D000077237:Arsenic Trioxide